HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases
Yıl: 2003 Cilt: 14 Sayı: 3 Sayfa Aralığı: 173 - 176 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases
Öz: Bu çalışmamızda HCV ile B hücreli lenfoproliferatif hastalıklar arasındaki ilişki araştırıldı. Yöntem: Çalışmaya B hücreli lenfoproliferatif hastalık'li hasta gurubundan olan B hücreli lenfoproliferatif hastalıklı 84 hasta, non B hücreli lenfoproliferatif hasta gurubundan olan Hodgin lenfomalı 50 hasta dahil edildi ve bu hastalarda anti-HCVpozitifliğine bakıldı. Kontrol gurubu olarak ise daha önce invaziv girişim ve kan transfüzyonu uygulanmamış, geçmişinde viral hepatit öyküsü olmayan 100 sağlıklı kan donöründe anti-HCV pozitifliğine bakıldı. Bulgular: Anti-HCV pozitifliği B hücreli lenfoproliferatif hastalarında, kontrol grubu ile karşılaştırıldığında, anlamlı olarak daha sık gözlenmiştir (7.1% vs. 1%, p<0.05). Hodgkin lenfoma hastalarında ise sıklık kontrol grubu ile benzerdir (2% vs. 1%, p<0.05). Sonuç: Bu bulgular HCV'nin B hücreli lenfoproliferatif hastalıklar gelişiminde bir rolü olabileceğini düşündürmektedir.
Anahtar Kelime: Konular:
Hodgkin ve non-Hodgkin lenfoma olgularında HCV prevalansı
Öz: Background/aims: In this study we aimed to investigate the relation between hepatitis C virus (HCV) and B cell lymphoproliferative diseases. Methods: Eighty-four patients with B-cell non-Hodgkin lymphoma and 50 patients with Hodgkin lymphoma were included. Control group consisted of another 100 otherwise healthy blood donors who had no previous history of invasive surgery, blood transfusions, and viral hepatitis. HCV positivity was investigated in both case groups and control group. Results: Anti-HCV positivity was significantly more frequent in B-cell non-Hodgkin lymphoma patients compared to control group (7.1% vs. 1%, p<0.05). In Hodgkin lymphoma patients however, frequency was comparable with the control group (2% vs. 1%, p<0.05). Conclusions: These findings suggest that HCV may play a role in the development of B-cell non-Hodgkin lymphoma, but not in Hodgkin lymphoma.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Silvestri F, Barillari G, Fanin R, et al. The genotype of the hepatitis C virus in patients with HCV-related B cell non- Hodgkin's lymphoma. Leukemia 1997; 11: 2157-61. 2. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62. 3. Sansonno D, De Vita S, Cornacchiulo V, et al. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996; 88: 4638-45. 4. Luppi M, Grazia Ferrari M, Bonaccorsi G, et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351-5. 5. De Rosa G, Gobbo ML, De Renzo A, et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Haematol 1997; 55: 77-82. 6. Pivetti S, Novarino A, Merico F, et al. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br J Haematol 1996; 95: 204-11. 7. Alter HJ, Prince AM. Transfusion-associated non-A, non-B hepatitis: an assessment of the causative agent and its clinical impact. Transfus Med Rev 1988; 2: 288-93. 8. Harada S, Watanabe Y, Takeuchi K, et al. Expression of processed core protein of hepatitis C virus in mammalian cells. J Virol 1991; 65: 3015-21. 9. Sehulster LM, Hollinger FB, Dreesman GR, et al. Immunological and biophysical alteration of hepatitis B virus antigens by sodium hypochlorite disinfection. Appl Environ Microbiol 1981; 42: 762-7. 10. Yenice N, Çolakoğlu Ö, Gül K, Canoruç F. [Prevalence of Hepatitis C virus among blood donors in Diyarbakir.] Gastroenteroloji 1993; 4: 41-2. 11. Sırmatel F, Baydar İ. [Demostration of HBV and HCV carriers with ELISA among risk groups in Gaziantep region]. Viral Hepatitle Savasim Derneği III. Viral Hepatit Sempozyumu Program ve Kongre Kitabi ,Istanbul 1996; P: 49. 12. Kocazeybek B, Erentürk S, Sönmez B, et al. (Prospective 3 years evaluation of anti-HCV prevalanca among blood donors: comparison of seropositive sera with RIBA and PCR). Türk Mikrobiyoloji Cemiyeti Dergisi 1995; 25: 135-141. 13. Özdemir R, Kestellioğlu F, Kurultay N, et al. [Investigation of anti-HCV among 192 cases admitted to İzmir Atatürk Devlet Hastanesi Kan Merkezi between 1.10.1993- 30.11.1993.] XXVII. Türk Mikrobiyoloji Kongre Kitabı, Antalya 1994; P: 263. 14. King PD, Wilkes JD, Diaz-Arias AA. Hepatitis C virus infection in non-Hodgkin's lymphoma. Clin Lab Haematol 1998; 20: 107-10. 15. Musolino C, Campo S, Pollicino T, et al. Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease. Haematologica 1996; 81: 162-4. 16. Ferri C, La Civita L, Monti M, et al. Chronic hepatitis C and B-cell non-Hodgkin's lymphoma. QJM 1996; 89: 117- 22. 17. Santini GF, Giannini F, Crovatto M, et al. HCV and lymphoproliferative diseases. Clin Exp Rheumatol 1995; 13 (Suppl 13): S51-7. 18. Arican A, Sengezer T, Bozdayi M, et al. Prevalence of hepatitis- G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma. Med Oncol 2000; 17: 123-6. 19. Paydaş S, Kilic B, Sahin B, Bugdayci R. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer. 1999; 80: 1303-5. 20. Kaya H, Polat MF, Erdem F, Gundogdu M. Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin's lymphoma. Clin Lab Haematol 2002; 24: 107-10. 21. Salem Z, Nuwaiyri-Salti N, Ramlawi F, et al. Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma. Eur J Epidemiol 2003; 18: 251-3. 22. Aviles A, Valdez L, Halabe J, et al. No association between lymphoma and hepatitis C virus. Med Oncol 2003; 20: 165- 8. 23. Shirin H, Davidovitz Y, Avni Y, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Isr Med Assoc J 2002; 4: 24-7. 24. Zuckerman E, Zuckerman T. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage. Blood Rev 2000; 16 (2): 119-25.
| APA | yenice n, GÜLLÜK F, ARICAN N, TÜRKMEN S (2003). HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. , 173 - 176. |
| Chicago | yenice necati,GÜLLÜK Fatih,ARICAN Nurten,TÜRKMEN Sembol HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. (2003): 173 - 176. |
| MLA | yenice necati,GÜLLÜK Fatih,ARICAN Nurten,TÜRKMEN Sembol HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. , 2003, ss.173 - 176. |
| AMA | yenice n,GÜLLÜK F,ARICAN N,TÜRKMEN S HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. . 2003; 173 - 176. |
| Vancouver | yenice n,GÜLLÜK F,ARICAN N,TÜRKMEN S HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. . 2003; 173 - 176. |
| IEEE | yenice n,GÜLLÜK F,ARICAN N,TÜRKMEN S "HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases." , ss.173 - 176, 2003. |
| ISNAD | yenice, necati vd. "HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases". (2003), 173-176. |
| APA | yenice n, GÜLLÜK F, ARICAN N, TÜRKMEN S (2003). HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turkish Journal of Gastroenterology, 14(3), 173 - 176. |
| Chicago | yenice necati,GÜLLÜK Fatih,ARICAN Nurten,TÜRKMEN Sembol HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turkish Journal of Gastroenterology 14, no.3 (2003): 173 - 176. |
| MLA | yenice necati,GÜLLÜK Fatih,ARICAN Nurten,TÜRKMEN Sembol HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turkish Journal of Gastroenterology, vol.14, no.3, 2003, ss.173 - 176. |
| AMA | yenice n,GÜLLÜK F,ARICAN N,TÜRKMEN S HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turkish Journal of Gastroenterology. 2003; 14(3): 173 - 176. |
| Vancouver | yenice n,GÜLLÜK F,ARICAN N,TÜRKMEN S HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turkish Journal of Gastroenterology. 2003; 14(3): 173 - 176. |
| IEEE | yenice n,GÜLLÜK F,ARICAN N,TÜRKMEN S "HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases." Turkish Journal of Gastroenterology, 14, ss.173 - 176, 2003. |
| ISNAD | yenice, necati vd. "HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases". Turkish Journal of Gastroenterology 14/3 (2003), 173-176. |
